- Home
- CCCC vs LEO Comparison
CCCC vs LEO Comparison
Compare CCCC & LEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCCC
- LEO
- Stock Information
- Founded
- CCCC 2015
- LEO 1987
- Country
- CCCC United States
- LEO United States
- Employees
- CCCC N/A
- LEO N/A
- Industry
- CCCC Biotechnology: Pharmaceutical Preparations
- LEO Trusts Except Educational Religious and Charitable
- Sector
- CCCC Health Care
- LEO Finance
- Exchange
- CCCC Nasdaq
- LEO Nasdaq
- Market Cap
- CCCC 396.0M
- LEO 394.9M
- IPO Year
- CCCC 2020
- LEO N/A
- Fundamental
- Price
- CCCC $4.01
- LEO $6.21
- Analyst Decision
- CCCC Buy
- LEO
- Analyst Count
- CCCC 6
- LEO 0
- Target Price
- CCCC $10.00
- LEO N/A
- AVG Volume (30 Days)
- CCCC 1.0M
- LEO 200.2K
- Earning Date
- CCCC 10-31-2024
- LEO 01-01-0001
- Dividend Yield
- CCCC N/A
- LEO 4.01%
- EPS Growth
- CCCC N/A
- LEO N/A
- EPS
- CCCC N/A
- LEO 0.04
- Revenue
- CCCC $33,668,000.00
- LEO N/A
- Revenue This Year
- CCCC $76.74
- LEO N/A
- Revenue Next Year
- CCCC N/A
- LEO N/A
- P/E Ratio
- CCCC N/A
- LEO $152.00
- Revenue Growth
- CCCC 65.45
- LEO N/A
- 52 Week Low
- CCCC $1.06
- LEO $4.98
- 52 Week High
- CCCC $11.88
- LEO $6.50
- Technical
- Relative Strength Index (RSI)
- CCCC 27.45
- LEO 41.78
- Support Level
- CCCC $3.84
- LEO $6.17
- Resistance Level
- CCCC $6.20
- LEO $6.36
- Average True Range (ATR)
- CCCC 0.49
- LEO 0.06
- MACD
- CCCC -0.19
- LEO 0.00
- Stochastic Oscillator
- CCCC 6.34
- LEO 50.00
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.
About LEO BNY Mellon Strategic Municipals Inc.
BNY Mellon Strategic Municipals, Inc. is a diversified closed-end management investment company. The fund's investment objective is to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital. Its products are Equity and Fixed Income Mutual Funds, Retail Money Market Funds, Government/Treasury Money Market Funds, Institutional Money Market Funds, and others.